ADIL (Adial Pharmaceuticals) Cyclically Adjusted Book per Share: $186.09 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ADIL Adial Pharmaceuticals Inc ADIL
30 GF Score
Price $5.94
! 1 Warning Sign
View Full Analysis

What is Adial Pharmaceuticals Cyclically Adjusted Book per Share?

Adial Pharmaceuticals ADIL +2.59% 30 Cyclically Adjusted Book per Share is $186.09 as of Jun. 2026. GuruFocus rates ADIL with a GF Score™ of 30/100. The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Adial Pharmaceuticals's adjusted book value per share for the three months ended in Jun. 2026 was $-14.614. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $186.09 for the trailing ten years ended in Jun. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-08-27), Adial Pharmaceuticals's current stock price is $5.94. Adial Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was $186.09. Adial Pharmaceuticals's Cyclically Adjusted PB Ratio of today is 0.03.

During the past 11 years, the highest Cyclically Adjusted PB Ratio of Adial Pharmaceuticals was 0.03. The lowest was 0.00. And the median was 0.00.


Adial Pharmaceuticals  (NAS:ADIL) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Adial Pharmaceuticals's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=5.94/186.09
=0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 11 years, the highest Cyclically Adjusted PB Ratio of Adial Pharmaceuticals was 0.03. The lowest was 0.00. And the median was 0.00.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Adial Pharmaceuticals Cyclically Adjusted Book per Share Related Terms


Adial Pharmaceuticals Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Adial Pharmaceuticals's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Adial Pharmaceuticals Cyclically Adjusted Book per Share Chart

Adial Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 186.44

Adial Pharmaceuticals Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 186.44 189.37 186.09

ADIL vs PULM, KAPA, ACXP: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Adial Pharmaceuticals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adial Pharmaceuticals Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Adial Pharmaceuticals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Adial Pharmaceuticals's Cyclically Adjusted PB Ratio falls into.


ADIL
30GF Score
Adial Pharmaceuticals Inc ADIL
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Adial Pharmaceuticals Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Adial Pharmaceuticals's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-14.614/333.9520*333.9520
=-14.614

Current CPI (Jun. 2026) = 333.9520.

Adial Pharmaceuticals Quarterly Data

Book Value per Share CPI Adj_Book
201609 0.000 241.428 0.000
201612 -11.444 241.432 -15.829
201703 0.000 243.801 0.000
201706 -51.778 244.955 -70.590
201709 -73.778 246.819 -99.823
201712 -110.889 246.524 -150.215
201803 -130.700 249.554 -174.902
201806 -129.400 251.989 -171.489
201809 492.900 252.439 652.058
201812 403.727 251.233 536.655
201903 733.188 254.202 963.209
201906 628.813 256.143 819.829
201909 545.625 256.759 709.664
201912 420.059 256.974 545.890
202003 326.529 258.115 422.467
202006 399.682 257.797 517.751
202009 308.043 260.280 395.234
202012 173.304 260.474 222.192
202103 200.643 264.877 252.967
202106 166.517 271.696 204.672
202109 218.182 274.310 265.620
202112 103.176 278.802 123.585
202203 281.763 287.504 327.284
202206 194.171 296.311 218.837
202209 125.791 296.808 141.533
202212 76.186 296.797 85.723
202303 31.304 301.836 34.635
202306 69.104 305.109 75.637
202309 47.735 307.789 51.793
202312 60.955 306.746 66.361
202403 37.790 312.332 40.406
202406 24.866 314.175 26.431
202409 22.984 315.301 24.344
202412 15.707 315.605 16.620
202503 7.996 319.799 8.350
202506 6.494 322.561 6.723
202509 4.727 324.800 4.860
202512 4.749 324.054 4.894
202603 2.463 330.213 2.491
202606 -14.614 333.952 -14.614

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $186.09 mean?
Adial Pharmaceuticals (ADIL) has a Cyclically Adjusted Book per Share of $186.09 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Adial Pharmaceuticals and its competitors.
Is Adial Pharmaceuticals' Cyclically Adjusted Book per Share too high?
Adial Pharmaceuticals' current Cyclically Adjusted Book per Share is $186.09. Overall, Adial Pharmaceuticals has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Adial Pharmaceuticals' Cyclically Adjusted Book per Share compare to PULM and KAPA?
Adial Pharmaceuticals' Cyclically Adjusted Book per Share of $186.09 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Adial Pharmaceuticals and its competitors. Adial Pharmaceuticals's current Cyclically Adjusted Book per Share is $186.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adial Pharmaceuticals stock overvalued right now?
Adial Pharmaceuticals (ADIL) has a current Cyclically Adjusted Book per Share of $186.09. The current Cyclically Adjusted Book per Share is $186.09. Adial Pharmaceuticals' overall GF Score™ is 30/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Adial Pharmaceuticals (ADIL), the current Cyclically Adjusted Book per Share is $186.09 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Adial Pharmaceuticals Business Description

Address 4870 Sadler Road, Suite 300, Glen Allen, VA, USA, 23060
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its investigational new drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. The company operates as one operating segment with a focus on drug development for addiction and related disorders.
30GF Score

Get the complete analysis for ADIL

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.94
Price